In a report released today, Joseph France from Cantor Fitzgerald maintained a Hold rating on Acadia Healthcare (NASDAQ: ACHC), with a price target of $39. The company’s shares opened today at $36.28.
France wrote:
“We rate ACHC Neutral primarily to reflect our view of the uncertainty associated with the recovery of its U.K. business, which accounts for 40% of the company’s revenue. $39 price target is based on comparable-company analysis and our DCF. The Disclosure Section may be found on pages 3 – 4.Valuation Our $39 price target reflects our reservations about the company’s ability to grow both organically and through acquisitions.”
According to TipRanks.com, France is a 5-star analyst with an average return of 10.8% and a 59.8% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and Addus Homecare Corp.
Currently, the analyst consensus on Acadia Healthcare is a Moderate Buy with an average price target of $41.25.
See today’s analyst top recommended stocks >>
The company has a one-year high of $45.27 and a one-year low of $26.92. Currently, Acadia Healthcare has an average volume of 958K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities, and Corporate and Other.
